Lucid Diligence Brief: UCB acquisition of Candid Therapeutics
Lucid Diligence Brief: UCB acquisition of Candid Therapeutics Professional…
Cell and Gene Therapy Today—April 23, 2026
This week’s Gene and Cell Therapy update highlights regulatory momentum,…
Rare Diseases Today—March 26, 2026
This week’s Rare Diseases update highlights regulatory designations, new…
Rare Disease Video Recap—February 26, 2026
This biweekly Rare Disease Video Recap covers key developments across the…
Rare Disease Video Recap—December 18, 2025
This biweekly Rare Disease Video Recap highlights the most significant…
Rare Disease Today—November 13, 2025
This week’s rare disease update spotlights key regulatory milestones,…
Rare Disease Video Recap—November 6, 2025
🎯 Watch Our Video Summary Capturing Rare Disease News from the Last Two Weeks…
Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!
Over the past few years, corporate venture capital (CVC) companies backed by or…